Purification and Characterization of Mature Murine and Human Satellite Glial Cells
Purification and Characterization of Mature Murine and Human Satellite Glial Cells
批准号:
9760015
负责人:
Temugin Berta
金额:
$20.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2021-08-31
关键词:
AblationAccelerationAcuteAdjuvant StudyAdultAfferent NeuronsAmericanAnimal ModelAnti-inflammatoryAntibodiesAstrocytesBiochemicalBioinformaticsCalciumCell AdhesionCellsCellular biologyCytokine ReceptorsDataDatabasesDevelopmentDiseaseExhibitsExposure toFreund&aposs AdjuvantFunctional disorderFutureGene Expression ProfileGene Expression ProfilingGene SilencingGenesGenetic TranscriptionGlycoproteinsGoalsHeadacheHealthHomeostasisHumanImageImmuneImmunohistochemistryIn Situ HybridizationIn VitroIndividualInflammationInflammatoryInterleukin-10Interleukin-4InvestigationLeadMethodsMicrogliaMolecularMolecular ProfilingMusNeurogliaNeuronsOutcomePainPain ResearchPain managementPathogenicityPatternPharmaceutical PreparationsPharmacologyPopulationPrevalenceProceduresProtocols documentationPublic HealthRNAResearchResearch PersonnelResolutionReverse Transcriptase Polymerase Chain ReactionRoleSensory GangliaSpecificitySpinal GangliaSurfaceSuspensionsTNF geneTemporomandibular Joint DisordersTestingTherapeuticTimeTrigeminal SystemUniversitiesWorkbasecell typechronic painchronic painful conditioncollaborative environmentcytokinegenetic manipulationgenetic signaturehuman tissuein vitro Modelinflammatory milieuinflammatory paininnovationinsightinterestmouse modelnew therapeutic targetnovelnovel strategiesnovel therapeutic interventionnovel therapeuticsoptogeneticspain processingpainful neuropathyreceptorreduce symptomsresponsescreeningside effecttooltranscriptome sequencingtranslational approach
中文摘要
超过1亿美国人患有慢性疼痛或严重疼痛。然而,目前的疼痛治疗方法是
低效并且伴随着不良的副作用。炎症反应和星形胶质细胞(SGCs)
感觉神经节是慢性疼痛的常见特征,如头痛、颞下颌关节紊乱病、
神经病理性和炎症性疼痛,它们可能代表新的治疗靶点。然而,目前还缺乏
有足够的工具直接审问成人的SGCs及其与炎症的相互作用。
在这项建议中,我们为成年鼠和人的研究建立了一个新的和变革性的工具
通过免疫泛屏,将细胞悬液涂在几个涂有特定抗原的培养皿上
抗体去除不需要的细胞类型,并使用最终的抗体涂层培养皿来选择细胞类型
利息。免疫泛素相对简单、廉价、对细胞温和,并且可以产生非常高的产量
用于转录、生化和药理学分析的纯化细胞。我们的长期目标是做得更好
了解神经元、神经胶质细胞和免疫细胞之间的不适应扰动如何参与疼痛和
如何针对它们开发更有效和更安全的治疗方法。主
本申请的目的是建立一种可靠的方案,用于表征和理解
成年小鼠和人SGCs的炎症病理生理学。我们的中心假设是
成年小鼠和人类的SGCs显示出一种独特的分子图谱,这种分子图谱可以通过
炎症表现出致病或保护功能的炎症这一假设将通过追查来检验
具体目标如下:(1)鉴定小鼠和人SGCs中的独特转录信号;
以及(2)小鼠和人SGC对炎症反应的特征。这些目标将会实现
通过免疫组化和RNA测序结合生物信息学、免疫组织化学、钙
成像、原位杂交和实时RT-PCR方法。拟议的工作具有创新性,因为它将
挑战偏向于排他神经机制和疼痛治疗的传统概念
并首次提供了对基因表达模式的全面、公正的分析和
小鼠和人类SGCs在健康和疾病条件下的功能特征。这些措施的结果是
调查将是:(1)建立一种简单且相对便宜的程序来分离一种大型、
和高度丰富的成熟SGCs种群,(2)小鼠和
人SGCs,(3)慢性胃炎小鼠模型炎症和SGCs功能的测定
(4)建立体外模型以研究这些功能在小鼠和人SGCs中的作用。这个
应用程序尤其重要,因为这些工具和数据库集应该会极大地帮助您
研究领域,并加快开发新的治疗方法,有效地抑制慢性疼痛。
英文摘要
More than 100 million Americans suffer from chronic pain or severe pain. However, current pain treatments are
inefficient and accompanied by undesirable side effects. Both inflammation and satellite glial cells (SGCs) in
sensory ganglia are common features of chronic pain such as headache, temporomandibular joint disorders,
neuropathic and inflammatory pain, and they may represent new therapeutic targets. However, there is a lack of
adequate tools for the direct interrogation of SGCs from adult individuals and their interactions with inflammation.
In this proposal we have established a new and transformative tool for the study of adult mouse and human
SGCs by immunopanning, which consists in passing a cell suspension over several dishes coated with specific
antibodies to deplete unwanted cell types, and a final antibody-coated dish being used to select the cell type of
interest. Immunopanning is relatively simple, inexpensive, gentle on cells, and can produce very high yields of
purified cells for transcriptional, biochemical and pharmacological analyses. Our long-term goal is to better
understand how maladaptive perturbations between neurons, glial and immune cells can participate in pain and
how they can be targeted for the development of more effective and safer therapeutic approaches. The main
objective of this application is to establish a reliable protocol for the characterization and understanding of the
inflammatory pathophysiology of adult murine and human SGCs. Our central hypothesis is that acutely isolated
SGCs from adult mice and humans exhibit a unique molecular profile that can be modulated by
inflammation to display either pathogenic or protective functions. This hypothesis will be tested by pursuing
the following specific aims: (1) Identification of a unique transcriptional signature in murine and human SGCs;
and (2) Characterization of murine and human SGC responses to inflammation. These aims will be accomplished
by immunopanning and RNA sequencing in combination with bioinformatics, immunohistochemical, calcium
imaging, in situ hybridization and real-time RT-PCR approaches. The proposed work is innovative because it will
challenge conventional concepts that are biased toward exclusive neuronal mechanisms and therapies of pain
and provide, for the first time, a comprehensive, unbiased analysis of the pattern of gene expression and
functional characterization of mouse and human SGCs in health and disease conditions. The outcomes of these
investigations will be (1) the establishment of a simple and relatively inexpensive procedure to isolate a large,
and highly enriched population of mature SGCs, (2) the identification of the molecular repertoire of mouse and
human SGCs, (3) the determination of the functions of inflammation and SGCs in a mouse model of chronic
pain, and (4) the establishment of an in vitro model to study these functions in mouse and human SGCs. The
application is particularly significant because these sets of tools and databases should greatly benefit the pain
research field and accelerate the development of new therapeutics to efficiently suppress chronic pain.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.jpain.2018.11.003
发表时间:
2019-05
期刊:
The journal of pain : official journal of the American Pain Society
影响因子:
--
作者:
[Raquel Tonello;Sang Hoon Lee;T. Berta]
通讯作者:
Raquel Tonello;Sang Hoon Lee;T. Berta
STING & PAIN: exploring a viral signaling protein in nociception and neuropathy
-
批准号:10195073
-
项目类别:
-
资助金额:$44.5万
-
财政年份:2021
-
负责人:Temugin Berta
-
依托单位:
海外基金